SCHEMBL845349

SCHEMBL845349

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3ccccc3-c3ccccc3)cc2)cc1)[C@@H]1CCCN1C(=O)c1ccccc1-c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 4/20 0.53
HCRTR2 O43614 4/20 0.53
TRPV1 Q8NER1 1/20 0.53
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
ALDH1A1 P00352 3/20 0.47
MAPK1 P28482 1/20 0.47
HTT P42858 1/20 0.47
KCNH2 Q12809 1/20 0.46
PABPC1 P11940 1/20 0.45
ROCK2 O75116 1/20 0.44
TSHR P16473 1/20 0.44
RECQL P46063 1/20 0.44
EP300 Q09472 1/20 0.44
CREBBP Q92793 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845704 0.91 TRPV1 (0.48) HCRTR1HCRTR2TRPV1CYP2C9CYP2C19
SCHEMBL13272272 0.87 TRPV1 (0.43) HCRTR1HCRTR2TRPV1CYP2C9CYP2C19
SCHEMBL845008 0.86 ALDH1A1 (0.54) CYP2C9CYP2C19ALDH1A1MAPK1HTT
SCHEMBL845566 0.85 ALDH1A1 (0.42) TRPV1CYP2C9CYP2C19ALDH1A1MAPK1
SCHEMBL845761 0.85 CYP2C9 (0.42) TRPV1CYP2C9CYP2C19ALDH1A1MAPK1
SCHEMBL13272509 0.85 TRPV1 (0.45) HCRTR1HCRTR2TRPV1CYP2C9CYP2C19
SCHEMBL845841 0.85 TRPV1 (0.45) HCRTR1HCRTR2TRPV1CYP2C9CYP2C19
SCHEMBL844996 0.85 CYP2C9 (0.50) TRPV1CYP2C9CYP2C19ALDH1A1MAPK1
SCHEMBL845443 0.85 CYP2C9 (0.47) TRPV1CYP2C9CYP2C19ALDH1A1MAPK1
SCHEMBL845257 0.85 TRPV1 (0.48) TRPV1CYP2C9CYP2C19ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed